Ask the dentist: New hope for sufferers of trigeminal neuralgia facial pain

A recent study from Zurich University has found that a novel substance with the catchy name, BIIB074, inhibits the sodium channels without the side affects that current medications have.

“Unlike conventional drugs, which often cause tiredness and concentration problems, BIIB074 was not only effective; but also very well tolerated,” explains Dominik Ettlin, a dental specialist from Zurich University.

“We will now test the new substance in a lot more subjects during the next study phase, which will reveal whether the new hope for more effective pain relief is justified,” he concludes.

Be the first to comment

Leave a Reply

Your email address will not be published.